The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments.
CONCLUSION: The microbiota-gut-brain axis might provide novel targets for prevention and treatment of neuropsychiatric disorders. However, further studies are required to substantiate the clinical use of probiotics, prebiotics and FMT.
PMID: 28925886 [PubMed - as supplied by publisher]
Source: Current Neuropharmacology - Category: Drugs & Pharmacology Authors: Kim YK, Shin C Tags: Curr Neuropharmacol Source Type: research
More News: Allergy & Immunology | Anxiety | Autism | Brain | Depression | Drugs & Pharmacology | Hormones | Neurology | Probiotics | Schizophrenia | Study